RXR activation — hope for new Parkinson’s disease treatment
September 26, 2009 by
Filed under nuclear medicine articles
RXR activation — hope for new Parkinson’s disease treatment
Researchers have investigated the potential of RXR ligands for the treatment of Parkinson’s disease. Writing in the open-access journal BMC Neuroscience the scientists describe the use of two cellular models of Parkinsonian damage to explore the neuroprotective function of the two RXR ligands LG268 and XCT.
Read more [...]